February 6, 2013
Conflict Minerals: What does Dodd-Frank Section 1502 mean for Companies in the Life Sciences Industry?
PricewaterhouseCoopers Panel Discussion, Washington, DC
People
PricewaterhouseCoopers Panel Discussion, Washington, DC
This site uses cookies to enhance functionality and performance. You may change your cookie settings at any time. If you do nothing, you are giving implied consent to the use of cookies on this website.